CRP and Alzheimer disease: This ApoE4 effect on inflammation was clearly demonstrated in the Framingham cohort, where participants with APOE4 and elevated plasma C-reactive protein (CRP) levels had a greater risk of developing late-onset of AD than age and sex-matched APOE2 and APOE3 carriers [19].